Beifen Sanpu GC-2010F Blood Ethanol Analysis System – Dedicated Headspace Gas Chromatograph with FID

Overview

The Beifen Sanpu GC-2010F Blood Ethanol Analysis System is a purpose-built headspace gas chromatography (HS-GC) platform engineered for the precise, legally defensible quantification of ethanol in whole blood specimens. It operates on the principle of equilibrium headspace sampling—leveraging the volatile nature of ethanol—to transfer analyte from the liquid phase into the vapor phase above the sample, followed by separation on a fused-silica capillary column and detection via flame ionization detection (FID). This methodology ensures high selectivity, low matrix interference, and robust reproducibility—critical requirements for forensic toxicology and clinical laboratory accreditation. The system is explicitly designed to comply with internationally aligned forensic standards, including SF/Z JD0107001–2016 (Judicial Identification Technical Specification for Ethanol Determination in Blood, issued by the Ministry of Justice of the PRC) and GA/T 842–2009 (Public Security Industry Standard for Determination of Ethanol in Blood, issued by the Ministry of Public Security). Its architecture supports GLP-compliant workflows, traceable calibration, and audit-ready data integrity.

Key Features

• Dedicated forensic configuration: Pre-optimized hardware and method parameters for blood ethanol analysis per SF/Z JD0107001–2016 and GA/T 842–2009.
• Integrated headspace autosampler (AHS-20A PLUS): Enables unattended, temperature- and time-controlled equilibration, pressurized loop injection, and minimal carryover (<0.01%).
• FID detector with linear dynamic range >10⁷ and optimized hydrogen/air flow stability for consistent response across 0.01–5.00 g/L ethanol concentrations.
• High-precision oven temperature control: Programmable ramping (0.1–26 °C/min), isothermal hold capability, and rapid cooling (≤374 °C/min) to support high-throughput forensic casework.
• Capillary inlet system with electronic pressure control (EPC): Ensures repeatable split/splitless injection and stable carrier gas delivery (N₂, H₂, or He) across full 0–472 kPa and 0–487 mL/min ranges.
• Injector capable of sustained operation up to 276 °C, compatible with derivatization-free analysis and internal standard (e.g., tert-butanol) co-injection protocols.

Sample Compatibility & Compliance

The GC-2010F system is validated for use with anticoagulated whole blood (e.g., K₂EDTA tubes), serum, and plasma matrices. Sample preparation follows standardized protein precipitation and internal standard addition prior to headspace vial sealing. All operational parameters—including equilibration temperature (60–80 °C), incubation time (15–30 min), and vial pressurization—are configurable to meet jurisdictional validation requirements. The platform meets essential elements of ISO/IEC 17025:2017 for testing laboratories, supports method validation per ICH Q2(R2), and provides documentation trails necessary for judicial admissibility under national evidence rules. Its design accommodates chain-of-custody integration and aligns with forensic quality management systems (QMS) requiring documented instrument qualification (IQ/OQ/PQ), calibration logs, and analyst training records.

Software & Data Management

Controlled by N3000 Chromatography Data System (CDS), the GC-2010F delivers full audit trail functionality compliant with FDA 21 CFR Part 11 principles—including electronic signatures, user access levels, event logging, and immutable raw data storage. Peak integration uses calibrated response factors relative to tert-butanol internal standard, with automatic baseline correction and retention time locking. Reports are exportable in PDF, CSV, and XML formats, supporting LIMS interfacing via ASTM E1384-compliant data exchange. All methods, sequences, and calibration curves are password-protected and version-controlled. Software validation packages—including installation qualification (IQ), operational qualification (OQ), and performance verification (PV)—are available upon request for forensic laboratory accreditation.

Applications

• Forensic toxicology: Quantitative ethanol determination in post-mortem, DUI/DWI, and criminal investigation blood samples.
• Clinical laboratories: Monitoring ethanol levels in patients presenting with suspected intoxication, metabolic disorders, or alcohol use disorder.
• Reference laboratories: Proficiency testing, method verification, and inter-laboratory comparison studies.
• Regulatory compliance: Supporting evidentiary requirements in traffic law enforcement, workplace safety programs, and medical-legal evaluations.
• Research applications: Pharmacokinetic modeling, post-absorptive ethanol metabolism studies, and matrix effect evaluation in alternative biological fluids.

FAQ

Why is blood ethanol measurement preferred over breath testing in legal contexts?
Blood ethanol concentration reflects the actual pharmacologically active dose in systemic circulation, whereas breath testing estimates blood concentration via a fixed 2100:1 partition ratio—subject to physiological variability, device calibration drift, and environmental interference. Courts universally recognize blood analysis as the primary evidentiary standard.
Does this system support dual-column confirmation per forensic best practices?
Yes—method development support includes dual-column validation using complementary stationary phases (e.g., DB-624 and DB-WAX), enabling orthogonal retention and enhanced specificity for courtroom-defensible results.
Is the system compatible with external LIMS or electronic case management systems?
The N3000 CDS supports ODBC connectivity and ASTM E1384-compliant data export, allowing seamless integration with major forensic LIMS platforms and digital evidence management systems.
What documentation is provided for regulatory audits?
Standard delivery includes IQ/OQ documentation, factory calibration certificates, SF/Z JD0107001–2016 conformance statement, GA/T 842–2009 validation report templates, and a complete set of SOP drafts for method implementation and daily system suitability testing.